{
    "2021-03-12": [
        [
            {
                "time": "",
                "original_text": "贝达药业：关于董事兼高管辞职的公告 董监高成员变化",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "董事",
                        "高管",
                        "辞职"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：董事、资深副总裁兼首席医学官LI MAO辞职",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "董事",
                        "首席医学官",
                        "辞职"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "LI MAO辞任贝达药业(300558.SZ)董事等职务 董监高成员变化",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "LI MAO",
                        "辞任",
                        "董事"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：董事LI MAO（毛力）辞职",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "董事",
                        "LI MAO",
                        "辞职"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：LI MAO辞去董事等职务 董监高成员变化",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "LI MAO",
                        "辞去",
                        "董事"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药企人的两会“朋友圈”： 创新热情正得到激发 关键点在基础研究",
                "features": {
                    "keywords": [
                        "药企",
                        "两会",
                        "创新",
                        "基础研究"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}